SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
321Another summary article on the state of RNAi, thanks to my Google alert. NothinThomas-1/2/2005
320I don't follow your logic. As far as I can tell from their PR, they give anNanoparticle-12/20/2004
319[Two RNAi Complexes, RITS and RDRC, Physically Interact and Localize to Noncodintuck-12/17/2004
318[Deregulated Akt3 activity promotes development of malignant melanoma] >>tuck-12/13/2004
317Another siRNA story from my Google sirna filter. Sounds like this could be an iThomas-12/13/2004
316Pardon me if I can't get excited. With that last PR, a company announces tIan@SI-12/10/2004
315Press Release Source: Intradigm Corporation Intradigm's ICS-283: First Demkeokalani'nui-12/10/2004
314Sirna Therapeutics Launches Dermatology Division Targeting Permanent Hair Removanigel bates-12/8/2004
313Silencing of Monocarboxylate Transporters via Small Interfering Ribonucleic Acidzeta1961-12/6/2004
312Prediction of gene function in mammals note: not sure *where* to put this - soJohn McCarthy-12/5/2004
311Intradigm uses nanoparticles and also claims successful in vivo delivery, so thetuck-12/3/2004
310Thanks, Tuck & WS, Appreciate the feedback. Here are the latest abstracts tThomas-12/3/2004
309Here's a few recent abstracts concerning off-target effects (I've postedtuck-12/1/2004
308Hi Thomas, I work in research, and some of the projects I am involved in periphWalkingshadow-12/1/2004
307Hello WS, Thanks for the reply. What is your area of expertise in this field, iThomas-12/1/2004
306Hi Thomas, I happen to work in this field. I can tell you that paper in NatureWalkingshadow-11/25/2004
305Another siRNA article about lack of immune response. I don't have access toThomas-11/24/2004
304Hi Tuck, Thanks for the responses and for looking into the targeting and deliverThomas-11/24/2004
303biz.yahoo.com Press Release Source: Sirna Therapeutics, Inc. Sirna TherapeuticsBulbaMan-11/23/2004
302Interesting post from Yahoo! that claims RNAI -- Sirna Therapeutics, that is -- tuck-11/22/2004
301Tuck, Wasn't aware of your RNAi board, so I posted some info on the biotech Arthur Radley-11/21/2004
300It's a good step, and ALNY bounced back into the $6 range on the news when ituck-11/18/2004
299Hi Tuck & all, Here is news from Alnylam on the delivery question (in vivo iThomas-11/18/2004
298Ooops. When I searched for the thread, " siliconinvestor.com " I founIan@SI-11/17/2004
297Don't say that to Bob Zagorin, Ian: Subject 4691tom pope-11/17/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News